Jefferies analyst, Chris Howerton, reiterated a Buy rating and $30.00 price target on Immunomedics (NASDAQ: IMMU) following negative commentary related ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE